ARCHIVES

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

This article is from The Cancer Letter archive.

Vol. 06 No. 24 | June 13, 1980

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Funding opportunities listed.

January 16, 2004

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

February 5, 1993

In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems

July 26, 1985